<SEC-DOCUMENT>0001193125-24-053647-index.html : 20240229 <SEC-HEADER>0001193125-24-053647.hdr.sgml : 20240229 <ACCEPTANCE-DATETIME>20240229171550 ACCESSION NUMBER: 0001193125-24-053647 CONFORMED SUBMISSION TYPE: S-8 PUBLIC DOCUMENT COUNT: 6 FILED AS OF DATE: 20240229 DATE AS OF CHANGE: 20240229 EFFECTIVENESS DATE: 20240229 FILER: COMPANY DATA: COMPANY CONFORMED NAME: 4D Molecular Therapeutics, Inc. CENTRAL INDEX KEY: 0001650648 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 473506994 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-8 SEC ACT: 1933 Act SEC FILE NUMBER: 333-277547 FILM NUMBER: 24705103 BUSINESS ADDRESS: STREET 1: 5858 HORTON STREET #455 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: 5105052680 MAIL ADDRESS: STREET 1: 5858 HORTON STREET #455 CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: 4D Molecular Therapeutics Inc. DATE OF NAME CHANGE: 20200506 FORMER COMPANY: FORMER CONFORMED NAME: 4D Molecular Therapeutics Inc DATE OF NAME CHANGE: 20150811 </SEC-HEADER> <DOCUMENT> <TYPE>S-8 <SEQUENCE>1 <FILENAME>d778402ds8.htm <DESCRIPTION>S-8 <TEXT> Document 1 - file: d778402ds8.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>2 <FILENAME>d778402dex51.htm <DESCRIPTION>EX-5.1 <TEXT> Document 2 - file: d778402dex51.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.2 <SEQUENCE>3 <FILENAME>d778402dex232.htm <DESCRIPTION>EX-23.2 <TEXT> Document 3 - file: d778402dex232.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-FILING FEES <SEQUENCE>4 <FILENAME>d778402dexfilingfees.htm <DESCRIPTION>EX-FILING FEES <TEXT> Document 4 - file: d778402dexfilingfees.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>g778402g0229053101172.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 5 - file: g778402g0229053101172.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>g778402g0229053101303.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 6 - file: g778402g0229053101303.jpg
</DOCUMENT> </SEC-DOCUMENT>